Crowdonomics
VISIBLE GENOMICS

Reg CF · Common Stock · Aug 2024

ClosedReached targetReg CFCommon Equity
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$0 / $1.2M max
0% of ceiling · target hit day 27
Investors
6
$2.7K avg
Post-money valuation
$26.4M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$16K$8K$0
630
Aug 4, 2024 · openedNov 6, 2024 · last reading
Target ($15K) hit — Aug 31, 2024, day 27Deadline Nov 5, 2024

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine, last checked Oct 4, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$33K
−$691K
FY2022
$32K
−$601K
FY2023
RevenueNet income
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$33,360
$31,768
Cost of goods sold
$25,613
$26,490
Gross margin
23%
17%
Net income
-$691,435
-$600,827
Taxes paid
$0
$0
Balance sheet
Cash
$8,973
$3,808
Accounts receivable
$1,600
$2,300
Total assets
$16,821
$12,651
Short-term debt
$1,457,387
$2,004,044
Long-term debt
$0
$0
Total liabilities
$1,457,387
$2,004,044
Other
Headcount
—
2

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$26.4M
Post-money$26.4M
Price / share$9.48
Shares offered1,582

Perks

Invest $1,000+ and receive 1 visible genomics test kit coupons$1K+

Offering details

Target$14,997
Max$1,234,998
Min investment$493
OpenedAug 4, 2024
DeadlineNov 5, 2024
ClosedNov 5, 2024
Days active93

Links & provenance

Source: Manual
0001665160-24-001147
Last synced Aug 18, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.